# Dose-Response Study of MR-107A-01 in The Treatment of Post-Surgical Dental Pain

> **NCT04571515** · PHASE2 · COMPLETED · sponsor: **Mylan Inc.** · enrollment: 114 (actual)

## Conditions studied

- Pain
- Postoperative Pain
- Pain, Acute

## Interventions

- **DRUG:** MR-107A-01
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04571515
- **Lead sponsor:** Mylan Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-09-29
- **Primary completion:** 2020-12-15
- **Final completion:** 2020-12-22
- **Target enrollment:** 114 (ACTUAL)
- **Last updated:** 2022-08-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04571515

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04571515, "Dose-Response Study of MR-107A-01 in The Treatment of Post-Surgical Dental Pain". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT04571515. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*